Menon KV, Shah V, Kamath PS: The budd-chiari syndrome. N Engl J Med. 2004, 350: 578-585. 10.1056/NEJMra020282.
Article
CAS
PubMed
Google Scholar
Aydinli M, Bayraktar Y: Budd-chiari syndrome: etiology, pathogenesis and diagnosis. World J Gastroenterol. 2007, 13: 2693-2696.
Article
PubMed
PubMed Central
Google Scholar
Valla DC: Primary budd-chiari syndrome. J Hepatol. 2009, 50: 195-203. 10.1016/j.jhep.2008.10.007.
Article
PubMed
Google Scholar
Shin SH, Chung YH, Suh DD, Shin JW, Jang MK, Ryu SH, Park NH, Lee HC, Lee YS, Suh DJ: Characteristic clinical features of hepatocellular carcinoma associated with budd-chiari syndrome: evidence of different carcinogenic process from hepatitis B virus-associated hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2004, 16: 319-324.
Article
PubMed
Google Scholar
Valla DC: The diagnosis and management of the budd-chiari syndrome: consensus and controversies. Hepatology. 2003, 38: 793-803.
Article
PubMed
Google Scholar
Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC: Budd-chiari syndrome: a review by an expert panel. J Hepatol. 2003, 38: 364-371.
Article
PubMed
Google Scholar
Katoh M, Shigematsu H: Primary liver carcinoma complicating membranous obstruction of the inferior vena cava. Pathol Int. 1999, 49: 253-257. 10.1046/j.1440-1827.1999.00856.x.
Article
CAS
PubMed
Google Scholar
Singh V, Sinha SK, Nain CK, Bambery P, Kaur U, Verma S, Chawla YK, Singh K: Budd-chiari syndrome: our experience of 71 patients. J Gastroenterol Hepatol. 2000, 15: 550-554. 10.1046/j.1440-1746.2000.02157.x.
Article
CAS
PubMed
Google Scholar
Gwon D, Ko GY, Yoon HK, Sung KB, Kim JH, Lee SS, Lee JM, Ohm JY, Shin JH, Song HY: Hepatocellular carcinoma associated with membranous obstruction of the inferior vena cava: incidence, characteristics, and risk factors and clinical efficacy of TACE. Radiology. 2010, 254: 617-626. 10.1148/radiol.09090738.
Article
PubMed
Google Scholar
Kawaguchi T, Sata M, Ono N, Sakisaka S, Koga H, Ijuin H, Mitsuyama K, Ueno T, Kage M, Tanikawa K: Budd-chiari syndrome complicated by hepatocellular carcinoma with no evidence of infection with hepatitis virus: a case report. Hepatogastroenterology. 1999, 46: 3237-3240.
CAS
PubMed
Google Scholar
Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J: Clinical management of hepatocellular carcinoma. Conclusions of the barcelona-2000 EASL conference. European association for the study of the liver. J Hepatol. 2001, 35: 421-430. 10.1016/S0168-8278(01)00130-1.
Article
CAS
PubMed
Google Scholar
Daniele B, Bencivenga A, Megna AS, Tinessa V: Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology. 2004, 127: S108-S112. 10.1053/j.gastro.2004.09.023.
Article
PubMed
Google Scholar
Bruix J, Sherman M: Management of hepatocellular carcinoma. Hepatology. 2005, 42: 1208-1236. 10.1002/hep.20933.
Article
PubMed
Google Scholar
Forner A, Vilana R, Ayuso C, Bianchi L, Sole M, Ayuso JR, Boix L, Sala M, Varela M, Llovet JM, et al: Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology. 2008, 47: 97-104.
Article
PubMed
Google Scholar
Lee KH, Sung KB, Lee DY, Park SJ, Kim KW, Yu JS: Transcatheter arterial chemoembolization for hepatocellular carcinoma: anatomic and hemodynamic considerations in the hepatic artery and portal vein. Radiographics. 2002, 22: 1077-1091.
Article
PubMed
Google Scholar
Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Sola R, et al: Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002, 359: 1734-1739. 10.1016/S0140-6736(02)08649-X.
Article
PubMed
Google Scholar
Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, Fan ST, Wong J: Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002, 35: 1164-1171. 10.1053/jhep.2002.33156.
Article
CAS
PubMed
Google Scholar
Moucari R, Rautou PE, Cazals-Hatem D, Geara A, Bureau C, Consigny Y, Francoz C, Denninger MH, Vilgrain V, Belghiti J, et al: Hepatocellular carcinoma in budd-chiari syndrome: characteristics and risk factors. Gut. 2008, 57: 828-835. 10.1136/gut.2007.139477.
Article
CAS
PubMed
Google Scholar
Vilgrain V, Lewin M, Vons C, Denys A, Valla D, Flejou JF, Belghiti J, Menu Y: Hepatic nodules in budd-chiari syndrome: imaging features. Radiology. 1999, 210: 443-450.
Article
CAS
PubMed
Google Scholar
Aoki K, Miyamoto T, Murata H, Kawahara K, Oka Y, Maeda S, Yamashita K: Significance of accessory hepatic venography to evaluate the intrahepatic venous system for obstruction of the inferior vena cava at the hepatic portion with main hepatic vein obstruction. Nihon Geka Gakkai Zasshi. 1986, 87: 704-
CAS
PubMed
Google Scholar
Simson IW: Membranous obstruction of the inferior vena cava and hepatocellular carcinoma in south africa. Gastroenterology. 1982, 82: 171-178.
CAS
PubMed
Google Scholar
Dilawari JB, Bambery P, Chawla Y, Kaur U, Bhusnurmath SR, Malhotra HS, Sood GK, Mitra SK, Khanna SK, Walia BS: Hepatic outflow obstruction (budd-chiari syndrome). experience with 177 patients and a review of the literature. Medicine (Baltimore). 1994, 73: 21-36.
Article
CAS
Google Scholar
Fattovich G, Stroffolini T, Zagni I, Donato F: Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004, 127: S35-S50. 10.1053/j.gastro.2004.09.014.
Article
PubMed
Google Scholar
Valla D: Hepatic venous outflow tract obstruction etiopathogenesis: asia versus the west. J Gastroenterol Hepatol. 2004, 19: S204-S211. 10.1111/j.1440-1746.2004.03642.x.
Article
Google Scholar
Brancatelli G, Federle MP, Grazioli L, Golfieri R, Lencioni R: Benign regenerative nodules in budd-chiari syndrome and other vascular disorders of the liver: radiologic-pathologic and clinical correlation. Radiographics. 2002, 22: 847-862.
Article
PubMed
Google Scholar
Winston CB, Schwartz LH, Fong Y, Blumgart LH, Panicek DM: Hepatocellular carcinoma: MR imaging findings in cirrhotic livers and noncirrhotic livers. Radiology. 1999, 210: 75-79.
Article
CAS
PubMed
Google Scholar
Brancatelli G, Vilgrain V, Federle MP, Hakime A, Lagalla R, Iannaccone R, Valla D: Budd-chiari syndrome: spectrum of imaging findings. AJR Am J Roentgenol. 2007, 188: W168-W176. 10.2214/AJR.05.0168.
Article
PubMed
Google Scholar
Chen MF, Hwang TL, Jeng LB, Wang CS, Jan YY, Chen SC: Postoperative recurrence of hepatocellular carcinoma. Two hundred five consecutive patients who underwent hepatic resection in 15 years. Arch Surg. 1994, 129: 738-742. 10.1001/archsurg.1994.01420310070012.
Article
CAS
PubMed
Google Scholar
Llovet JM, Fuster J, Bruix J: The barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl. 2004, 10: S115-S120. 10.1002/lt.20034.
Article
PubMed
Google Scholar
Bruix J, Sala M, Llovet JM: Chemoembolization for hepatocellular carcinoma. Gastroenterology. 2004, 127: S179-S188. 10.1053/j.gastro.2004.09.032.
Article
CAS
PubMed
Google Scholar
Greten TF, Papendorf F, Bleck JS, Kirchhoff T, Wohlberedt T, Kubicka S, Klempnauer J, Galanski M, Manns MP: Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br J Cancer. 2005, 92: 1862-1868. 10.1038/sj.bjc.6602590.
Article
CAS
PubMed
PubMed Central
Google Scholar
Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, Matsuyama Y, Nakanuma Y, Kojiro M, Makuuchi M, et al: Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology. 2006, 131: 461-469. 10.1053/j.gastro.2006.05.021.
Article
CAS
PubMed
Google Scholar
Hatanaka Y, Yamashita Y, Takahashi M, Koga Y, Saito R, Nakashima K, Urata J, Miyao M: Unresectable hepatocellular carcinoma: analysis of prognostic factors in transcatheter management. Radiology. 1995, 195: 747-752.
Article
CAS
PubMed
Google Scholar
Savastano S, Miotto D, Casarrubea G, Teso S, Chiesura-Corona M, Feltrin GP: Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child’s grade a or B cirrhosis: a multivariate analysis of prognostic factors. J Clin Gastroenterol. 1999, 28: 334-340. 10.1097/00004836-199906000-00010.
Article
CAS
PubMed
Google Scholar